-
Je něco špatně v tomto záznamu ?
Plasma levels of glial cell marker S100B in children with autism
A. Tomova, P. Keményová, D. Filčíková, Ž. Szapuová, A. Kováč, K. Babinská, D. Ostatníková
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- autistická porucha krev moč MeSH
- dítě MeSH
- feces chemie MeSH
- leukocytární L1-antigenní komplex analýza MeSH
- lidé MeSH
- předškolní dítě MeSH
- S-100 kalcium vázající protein G, podjednotka beta krev MeSH
- serotonin moč MeSH
- studie případů a kontrol MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- Publikační typ
- časopisecké články MeSH
Autism spectrum disorder (ASD) is a neurodevelopmental condition with increasing incidence. Recent evidences suggest glial cells involvement in autism pathophysiology. S100B is a calcium binding protein, mainly found in astrocytes and therefore used as a marker of their activity. In our study, children with autism had higher plasma concentrations of S100B compared to non-autistic controls. No association of S100B plasma levels with behavioral symptoms (ADI-R and ADOS-2 scales) was found. Plasma S100B concentration significantly correlated with urine serotonin, suggesting their interconnection. Correlation of plasma S100B levels with stool calprotectin concentrations was found, suggesting not only brain astrocytes, but also enteric glial cells may take part in autism pathogenesis. Based on our findings, S100B seems to have a potential to be used as a biomarker of human neurodevelopmental disorders, but more investigations are needed to clarify its exact role in pathomechanism of autism.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21028184
- 003
- CZ-PrNML
- 005
- 20220328170757.0
- 007
- ta
- 008
- 211105s2019 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934350 $2 doi
- 035 __
- $a (PubMed)31928049
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Tomová, Alexandra $7 xx0239834 $u Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic
- 245 10
- $a Plasma levels of glial cell marker S100B in children with autism / $c A. Tomova, P. Keményová, D. Filčíková, Ž. Szapuová, A. Kováč, K. Babinská, D. Ostatníková
- 504 __
- $a Literatura
- 520 9_
- $a Autism spectrum disorder (ASD) is a neurodevelopmental condition with increasing incidence. Recent evidences suggest glial cells involvement in autism pathophysiology. S100B is a calcium binding protein, mainly found in astrocytes and therefore used as a marker of their activity. In our study, children with autism had higher plasma concentrations of S100B compared to non-autistic controls. No association of S100B plasma levels with behavioral symptoms (ADI-R and ADOS-2 scales) was found. Plasma S100B concentration significantly correlated with urine serotonin, suggesting their interconnection. Correlation of plasma S100B levels with stool calprotectin concentrations was found, suggesting not only brain astrocytes, but also enteric glial cells may take part in autism pathogenesis. Based on our findings, S100B seems to have a potential to be used as a biomarker of human neurodevelopmental disorders, but more investigations are needed to clarify its exact role in pathomechanism of autism.
- 650 _2
- $a autistická porucha $x krev $x moč $7 D001321
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a feces $x chemie $7 D005243
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a leukocytární L1-antigenní komplex $x analýza $7 D039841
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a S-100 kalcium vázající protein G, podjednotka beta $x krev $7 D064568
- 650 _2
- $a serotonin $x moč $7 D012701
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Keményová, Petra $7 _AN073378 $u Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic
- 700 1_
- $a Filčíková, Diana $7 xx0236245 $u Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic
- 700 1_
- $a Szapuová, Žofia. $7 xx0271103 $u Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic
- 700 1_
- $a Kováč, Andrej $7 xx0267417 $u Slovak Academy of Sciences, Institute of Neuroimmunology, Bratislava, Slovak Republic
- 700 1_
- $a Babinská, Katarína $7 xx0070683 $u Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic
- 700 1_
- $a Ostatníková, Daniela, $d 1957- $7 xx0104046 $u Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 68, Suppl 3 (2019), s. S315-S323
- 773 0_
- $t Proceedings of the ... Physiological days $g (2019), s. S315-S323 $w MED00183838
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31928049 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20211105 $b ABA008
- 991 __
- $a 20220328170755 $b ABA008
- 999 __
- $a ok $b bmc $g 1735505 $s 1148729
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 68 $c Suppl 3 $d S315-S323 $e 20191220 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC __
- $a 2019 $d S315-S323 $m Proceedings of the ... Physiological days $x MED00183838
- LZP __
- $b NLK118 $a Pubmed-20211105